Specialty Pharmaceuticals | The Payer Perspective
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Specialty Pharmaceuticals | The Payer Perspective
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Presented at: Specialty Pharmaceutical Summit 2025 SPS Puerto Rico
Summit Directors:
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE | Baptist Health South Florida
Bhavesh Shah, RPh, BCOP | Boston Medical Center
Specialty Pharmaceuticals | The Payer Perspective
Moderator: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC,FACHE | Baptist Health South Florida
Panel: Iris L. Morant Rodriguez, BS Pharm, RPh | MSO Puerto Rico; Gladiany Ramos-Marrero, PharmD, RPh, CSP | MCS Puerto Rico; Nury Toledo Nunez, PharmD | SSS HealthPuerto Rico
The panel explored Puerto Rico’s healthcare landscape, noting heavy reliance on Triple S, MMM, and MCs, with a$5.8 billion 2025 budget dominated by Medicare and oncology costs. Key challenges include underfunding, specialty drug management, and the need for stakeholder collaboration, biosimilars, and AI integration to improve outcomes.